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ABSTRACT Infection with uropathogenic Escherichia coli (UPEC), the causative agent of most uncomplicated urinary tract infec-
tions,proceedsinanascendingmannerand,ifleftuntreated,mayresultinbacteremiaandurosepsis.Toexaminethefateof
UPECafteritsentryintothebloodstream,wedevelopedamurinemodelofsublethalbacteremia.CBA/Jmicewereinoculated
intravenously with 1  106 CFU of pyelonephritis strain E. coli CFT073 carrying a bioluminescent reporter. Biophotonic imag-
ing,usedtomonitortheinfectionover48h,demonstratedthatthebacteriadisseminatedsystemicallyandappearedtolocalize
atdiscretesites.UPECwasrecoveredfromthespleen,liver,kidneys,lungs,heart,brain,andintestinesasearlyas20minpostin-
oculation, peaking at 24 h postinoculation. A nonpathogenic E. coli K-12 strain, however, disseminated at signiﬁcantly lower
levels(P<0.01)andwasclearedfromtheliverandcecumby24hpostinoculation.Isogenicmutantslackingtype1ﬁmbriae,P
ﬁmbriae,capsule,TonB,thehemereceptorsHmaandChuA,orparticularlythesialicacidcatabolismenzymeNanAweresigniﬁ-
cantlyoutcompetedbywild-typeCFT073duringbacteremia(P<0.05),whileﬂagellinandhemolysinmutantswerenot.
IMPORTANCE E. coli is the primary cause of urinary tract infections. In severe cases of kidney infection, bacteria can enter the
bloodstream and cause systemic disease. While the ability of E. coli to cause urinary tract infection has been extensively studied,
thefateofthesebacteriaoncetheyenterthebloodstreamislargelyunknown.Hereweusedanimagingtechniquetodevelopa
mouse model of E. coli bloodstream infection and identify bacterial genes that are important for the bacteria to spread to and
infect various organs. Understanding how urinary tract pathogens like E. coli cause disease after they enter the bloodstream may
aidinthedevelopmentofprotectiveandtherapeutictreatments.
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U
ropathogenic Escherichia coli (UPEC), a subset of extraintes-
tinal pathogenic E. coli (ExPEC), is the causative agent of
most cases of uncomplicated urinary tract infection (UTI). UTIs
proceedinanascendingmanner,beginningwithbacterialcoloni-
zation of the bladder, followed by ascension to the kidneys. In
severecasesofpyelonephritis,bacteriacancrosstheepithelialcells
of the proximal tubule and the endothelial cells of the capillary
and gain access to the bloodstream, causing bacteremia and occa-
sionallysepsis.InarecentstudyofbacteremicUTIs,E.coliwasthe
most common pathogen, responsible for nearly 75% of all Gram-
negative bacteremias (1). Bacteremia, deﬁned as the presence of
bacteria in the bloodstream (2), can lead to sepsis, which is a
systemic inﬂammatory response that may lead to organ dysfunc-
tion.
Virulence determinants that contribute to UPEC colonization
of the urinary tract include ﬁmbrial adhesins (3, 4), ﬂagellin (5),
secreted proteins (6), polysaccharide capsule (7), ferric iron ac-
quisition systems (8), and speciﬁc metabolic pathways (9, 10).
Besides hemolysin, which has been implicated in urosepsis (11),
theextenttowhichtheseuropathogenicityfactorsalsocontribute
to virulence once UPEC gains access to the bloodstream is not
known. However, extensive epidemiological data have correlated
thepresenceofspeciﬁcvirulencegenes,includingthosefortoxins,
iron acquisition determinants, and P ﬁmbrial adhesins, with
E. coli urosepsis (12–14).
Although commensal E. coli (2) and UPEC (2, 11) strains have
been tested at high doses intravenously, no nonlethal model of
pathogenic E. coli bacteremia currently exists; ExPEC virulence,
however,hasbeenexaminedusingseveralvertebrateandinverte-
brate sepsis models. A lethal sepsis mouse model, using a subcu-
taneousinfectionroute,wasabletodifferentiatepathogenicfrom
nonpathogenicE.colistrains(15)andhasbeenusedsubsequently
to assess the virulence of isogenic mutants (16). A similar lethal
sepsis model using an intraperitoneal infection route was used to
assess the efﬁcacy of putative ExPEC vaccine candidates in mice
(17). More recently, nonmammalian models of ExPEC lethality
have been explored, including Caenorhabditis elegans (18) and
African migratory locusts (19). Various ExPEC and nonpatho-
genic E. coli strains were also tested in a lethal zebraﬁsh model of
systemic infection which was subsequently used to differentiate
the roles of two secreted toxins (21).
WhileExPECsepsismodelscontributetotheunderstandingof
ExPEC virulence factor function, they may not be reﬂective of
UPECpathogenesisafterentryintothebloodstream.Manysepsis
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thanthebloodstream.Furthermore,bacteriaareusuallydelivered
at high doses, leading to massive inﬂammatory responses and
rapid death, therefore representing severe sepsis, not the natural
progression of bacteremia. Large bacterial doses also result in the
delivery of high concentrations of lipopolysaccharide (LPS),
which has profound effects on host inﬂammation. In contrast,
UPECpassagefromthekidneysintothebloodstreamlikelyoccurs
at doses well below the median lethal dose (LD50). While this
initial bacteremia can progress to sepsis, it is important to under-
standtheearlyeventsthatoccurafterUPECentersthecirculation.
Here,weutilizedinvivobioluminescenceimaging,usedprevi-
ously to monitor bacterial infections within mammalian hosts
(20),todevelopamurinemodelofUPECbacteremia.Thisreport
demonstrates that after intravenous inoculation of a sublethal
dose, UPEC disseminates systemically and inﬁltrates speciﬁc tis-
sues; a nonpathogenic E. coli K-12 strain is quickly cleared. We
also show that several well-characterized urovirulence factors
contributetoUPECdissemination,andwedemonstratethepres-
ence of bacteremia-speciﬁc ﬁtness factors.
RESULTS
Development of a murine model of bacteremia. To examine the
pathogenesisofUPECinthebloodstream,wedevelopedamurine
model of E. coli bacteremia. Prototypical pyelonephritis strain
E. coli CFT073 is a urosepsis strain isolated from both the blood
and urine of a patient with acute pyelonephritis (22). Female
CBA/J mice were inoculated intravenously via tail vein injection
with CFT073 carrying a stable luminescent reporter, pGEN-lux
(20), at various doses. At 3 h postinoculation (hpi), the bacterial
loadinthespleenwasassessedasanindicatorofbacteremia.Bac-
teria could be recovered from the spleens of animals inoculated
with a dose as low as 103 CFU/mouse (Fig. 1A). Spleens excised
20 min postinoculation from infected animals were luminescent
(Fig. 1C), indicating that the bacteremia was due to
CFT073(pGEN-lux). The median infectious dose (ID50) was de-
termined to be 105 CFU/mouse and yielded a median bacterial
load of approximately 103 CFU/g spleen. For comparison, the
ID50 for transurethral inoculation of this urinary isolate is
106CFU/mouse(23).Toensureinfectionofalargerproportionof
the population, 10 times the ID50 (106 CFU/mouse) was used for
all subsequent experiments.
Usingbiophotonicimaging,infectedmiceweremonitoredfor
signs of bacterial dissemination. Immediately following inocula-
tion (0.3 hpi), the bioluminescent signal was restricted to areas
near the injection site in 4 of 10 mice but detected in the upper
thoracicregionin6of10mice(Fig.1B).Thespleenisolatedfrom
a mouse with ventral luminescence at 0.3 hpi (similar to the
mouse shown in Fig. 1B) was also luminescent (Fig. 1C) and con-
tained~105CFU,indicatingthatatleastpartofthewhole-animal
signal was due to splenic inﬁltration. Overall, ventrally measured
luminescence decreased slightly over time, while the signal de-
tected from the dorsal side increased (Fig. 1D). Indeed, by 24 hpi,
an intense luminescent signal was detected in the lower abdomen
and sacral area of inoculated mice (Fig. 1B). This signal persisted
and appeared to have spread further by the experimental end-
point, 48 hpi. Excision and ex vivo imaging of the ileum, cecum,
and colon at 48 hpi revealed luminescence in these organs
(Fig. 1C), indicating that bacterial colonization in the intestinal
tract was at least partially responsible for the abdominal signal
observedinliveanimals.Thesedatasuggestthat,whenintroduced
intothebloodstream,UPECiscapableofsystemicdissemination.
Intravenous inoculation of UPEC leads to tissue inﬁltration
and systemic colonization. To determine the extent to which
UPEC disseminates during bacteremia, groups of mice were in-
travenously challenged with 106 CFU CFT073(pGEN-lux) and
bacteria present in systemic tissues were quantiﬁed throughout
the infection. Immediately following inoculation (20 min postin-
oculation), bacteria were present in the spleen, liver, kidneys,
lungs, heart, brain, duodenum, ileum, and cecum, with the high-
est bacterial loads found in the spleen and liver (Fig. 2). Culture
plateswereimaged,andallcolonieswerefoundtobeluminescent
(Fig. 2F, inset), indicating that the enumerated bacteria repre-
sented the inoculated strain.
In most tissues, bacterial colonization decreased over time, al-
though duodenum and cecal colonization remained relatively
constant through 48 hpi (Fig. 2G and J). This is consistent with
biophotonicimagingdatawhichdemonstrateadecreaseinupper
ventral luminescence and an increase in lower ventral and dorsal
signals (Fig. 1). In the liver (Fig. 2B), kidneys (Fig. 2C), lungs
(Fig. 2D), heart (Fig. 2E), brain (Fig. 2F), and ileum (Fig. 2I),
bacterial loads fell below the limit of detection by 48 hpi. While
bacteria present in the liver and kidneys were cleared slowly over
the course of the experiment, UPEC bacteria were cleared from
the lungs, brain, and ileum as early as 4 hpi and from the heart by
24hpi.Exceptionswerethejejunum(Fig.2H)andfeces(Fig.2L),
wherebacteriawerenotdetecteduntil24hpi.Thecolon(Fig.2K)
andbladder(datanotshown)weretheonlyorgansexaminedthat
didnotcontainbacteriainmeasurablenumbersatanypointdur-
inginfection.Becausebioluminescencewasobservedinthecolon
exvivoat48hpi(Fig.1C),thissuggeststhatUPEConlysometimes
disseminates to the colon or that the luminescent signal detected
wasduetoluminal(orfeces-associated)andnottissue-associated
bacteria. Taken together, these data indicate that UPEC dissemi-
nates systemically during bacteremia and appears to persist in
speciﬁc intestinal tissues for at least 2 days postinoculation (dpi).
Tissue perfusion does not eliminate bacterial inﬁltration.
Onepossibleexplanationforwidespreaddisseminationandorgan
colonization is that UPEC remains in the bloodstream after inoc-
ulation and that the dissemination observed was simply due to
bacteria present in organ-associated blood vessels and did not
represent colonization of speciﬁc tissues. To test this hypothesis,
intravenously inoculated mice were perfused immediately after
euthanasiaat24hpiwith40mlsterilesalinebeforeorganexcision
and processing. Gross organ blanching was used as an indication
that blood was depleted from the body and perfusion was com-
plete (24), although complete blanching of the spleen was not
observed. Bacterial levels in the liver, cecum, kidneys, and brain
were not signiﬁcantly different between nonperfused and per-
fusedanimals(Fig.3).Incontrast,perfusionsigniﬁcantlyreduced
bacterial levels in the lungs (P  0.0196), with undetectable levels
inﬁveofsixperfusedmice,indicatingthatnearlyallofthebacteria
recovered from the lungs were due to circulating UPEC. Perfused
micealsohadlowerlevelsofbacteriaintheirspleens(P0.0290),
although the median bacterial load was still greater than
104 CFU/g, indicating that both circulating and tissue-associated
bacteria contributed to splenic inﬁltration. Overall, these data
show that most of the bacterial inﬁltration observed was indeed
duetotissuecolonizationandnotmerelythepresenceofcirculat-
ing blood.
Smith et al.
2 mbio.asm.org November/December 2010 Volume 1 Issue 5 e00262-10UPECsystemiccolonizationpersistslongerthanacommen-
sal E. coli strain. To determine whether systemic dissemination
by UPEC is a pathogen-speciﬁc process or simply represents the
natural course of bacterial clearance from the bloodstream, non-
pathogenic E. coli K-12 strain MG1655 was tested in the bactere-
mia model. At 24 hpi, the spleen and liver (Fig. 4A) contained
signiﬁcantly lower levels of MG1655(pGEN-lux) than
CFT073(pGEN-lux)( P  0.0024 and P  0.0087, respectively).
Mice infected with MG1655 also had lower levels of cecal coloni-
zation, although this difference was not signiﬁcant at 24 hpi. To
examine the persistence dynamics of these strains, cecal coloniza-
tionwasexaminedatupto7dpi.BecausepGEN-luxisonlystably
maintained in CFT073 for 48 h in the absence of antibiotic selec-
tion (20), isogenic lacZ mutants of CFT073 and MG1655 were
used to allow differentiation from the cecal microbiota. Thus,
while it is important to note that this represents a method of bac-
terial quantiﬁcation different from that shown previously (Fig. 2
and 4A) that does not depend on the presence of pGEN-lux, cecal
FIG1 Real-time imaging of UPEC dissemination during bacteremia. (A) Splenic bacterial loads at 3 hpi following intravenous inoculation of CBA/J mice with
the indicated doses of E. coli CFT073(pGEN-lux). Filled circles represent numbers of CFU/g from individual animals, and bars show the medians. The limit of
detectionwas100CFU/g.(B)Biophotonicimagingoftheventral(top)anddorsal(bottom)sidesofalivemouseat0.3(left),4(leftcenter),24(rightcenter),and
48(right)hfollowingintravenousinoculationwith106CFU.(C)Biophotonicimagingofanexcisedspleen(bottomleft)at0.3handtheileum(topleft),colon
(topright),andcecum(bottomright)at48hfollowinginoculationasdescribedforpanelB.(D)Quantiﬁcationofluminescenceimagedfromthethoracicventral
(left) and dorsal (right) sides of mice inoculated as described for panel B. Mean luminescence is shown, and error bars represent the standard error of the mean
(n  10).
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CFT073lacZat24hpi(datanotshown).WhileCFT073coloniza-
tion persisted in the cecum at 72 hpi at nearly 104 CFU/g, E. coli
MG1655 was cleared by this time point from 9 of 10 mice (P 
0.0001)(Fig.4B).By7dpi,CFT073hadbeenclearedfromthececa
of 7 of 10 mice. These data indicate that nonpathogenic E. coli is
not capable of persisting systemically during bacteremia in this
model and suggest that UPEC dissemination and persistence rep-
resent pathogenic mechanisms.
Hemeacquisition,adherence,capsule,andsialicacidmetab-
olism contribute to UPEC ﬁtness in the bloodstream. The ﬁnd-
ing that UPEC is more effective at bacteremic dissemination or
more resistant to immune clearance than E. coli MG1655 is sug-
gests that UPEC-speciﬁc factors play a role in systemic coloniza-
tion. We hypothesized that some, but likely not all, of the genes
known to play a role in uropathogenesis may be important for
virulence during bacteremia. To address this, isogenic mutants
defective for recognized UPEC ﬁtness factors were tested in co-
challenge studies in our bacteremia model. Each mutant and the
wild type were mixed in equal proportions and inoculated intra-
venously to yield a total dose of 106 CFU per mouse. At 24 hpi,
bacteria were quantiﬁed in the spleen and liver and competitive
indices (CIs) were calculated for each mutant (Table 1).
Both a P ﬁmbria-deﬁcient strain (pap) and a type 1 ﬁmbria
phase locked-OFF strain that does not produce type 1 ﬁmbriae
(ﬁmL-OFF)wereoutcompetedbywild-typeCFT073inthespleen
FIG 2 Systemic dissemination of UPEC after intravenous inoculation. Bacterial recovery from the (A) spleen, (B) liver, (C) kidneys, (D) lungs, (E) heart,
(F) brain, (G) duodenum, (H) jejunum, (I) ileum, (J) cecum, (K) colon, and (L) feces at 20 min (0.3 h) to 48 hpi intravenously with 106 CFU E. coli
CFT073(pGEN-lux). Inset, bioluminescent image of bacterial colonies recovered from brain tissue at 0.3 hpi. Filled circles represent individual mice, and bars
show the medians. The limit of detection was 100 CFU/g.
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mediatedadherencecontributestoUPEC
systemiccolonization(Fig.5).AK2poly-
saccharide capsule mutant (ksl) found
previously to exhibit increased serum
susceptibility (7) was outcompeted by
CFT073Nalinthespleenandliveralso,in-
dicating that capsule contributes to
UPEC bacteremic ﬁtness. In contrast,
neither a nonmotile ﬂagellin mutant
(ﬂiC) nor an alpha-hemolysin mutant
(hlyD),bothofwhichhavebeenshownto
contribute to UPEC urovirulence (5, 25),
were signiﬁcantly outcompeted by wild-
type CFT073 in either tissue.
Ironacquisition,whichisrequiredfor
UPEC colonization of the urinary tract
(8), would be predicted to contribute ap-
preciably to survival in the bloodstream.
AtonBdeletionmutantwhichisdefective
for growth under iron limitation was sig-
niﬁcantly outcompeted in both the
spleens and livers of infected mice (Fig. 5), indicating that ferric
iron acquisition does contribute to UPEC systemic colonization.
To more closely examine the role of iron acquisition during bac-
teremia, we tested in a cochallenge a heme uptake-defective hma
chuA mutant which lacks both TonB-dependent heme receptors
(26). This mutant was also outcompeted in the spleen and liver
during bacteremia, demonstrating that heme uptake contributes
to UPEC pathogenesis in this model. Surprisingly, the median CI
ofthehmachuAmutantintheliverwasnearly10-foldlowerthan
that of the tonB mutant (P  0.0039), indicating that the hma
chuA mutant was signiﬁcantly less ﬁt during bacteremia than the
tonB mutant was.
UPECsystemicdisseminationduringbacteremiarequiresthat
bacteriautilizecarbonsourcesavailableinthehost.Sialicacidisa
major component of erythrocyte membrane glycoproteins, and
E. coli is able to use this amino sugar as a carbon source (27).
Although sialic acid catabolism does not contribute to UPEC
ﬁtness in the murine urinary tract (9), we hypothesized that it
may contribute to bacterial survival in the bloodstream. The
E. coli enzyme N-acetylneuraminate aldolase, encoded by nanA,
catalyzes the breakdown of N-acetylneuraminic acid, the major
sialic acid in mammalian cells, into pyruvate and
FIG 3 Tissue inﬁltration following perfusion. Shown are bacterial loads at 24 h following tail vein
inoculation of CBA/J mice with 106 CFU E. coli CFT073(pGEN-lux). Organs were harvested immedi-
ately(closedsymbols)orfollowingpostmortemwhole-animalcardiacperfusionwith40mlPBS(open
symbols). Data for nonperfused animals (closed symbols) were taken from the experiment shown in
Fig. 2. Bars show the medians. The limit of detection was 100 CFU/g. Statistically signiﬁcant P values
(0.05) are indicated.
FIG 4 Systemic tissue colonization by and persistence of E. coli CFT073 and
a commensal K-12 strain. (A) Bacterial loads at 24 h following an intravenous
challenge with 106 CFU E. coli CFT073(pGEN-lux) (solid symbols) or E. coli
K-12 strain MG1655(pGEN-lux) (open symbols). (B) Bacterial loads in cecal
tissue at 3 and 7 days following an intravenous challenge with 106 CFU E. coli
CFT073 lacZ (solid symbols) or E. coli K-12 strain MG1655 lacZ (open
symbols). Symbols represent individual animals, and bars show the medians.
Thelimitofdetectionwas100CFU/g.StatisticallysigniﬁcantPvalues(0.05)
are indicated.
TABLE 1 CIs of UPEC virulence factor mutants in a murine
cochallenge model of bacteremia
Spleen Liver
Mutant CIa P value CI P value
ﬁm L-OFF 0.280 0.0039b 0.257 0.0391b
pap 0.272 0.0039b 0.236 0.0039b
ﬂiC 0.710 0.1602 0.228 0.0840
hlyD 0.874 0.4922 0.957 0.6953
ksl 0.396 0.0234b 0.303 0.0078b
tonB 0.353 0.0009b 0.264 0.0034b
hma chuA 0.183 0.0001b 0.043 0.0039b
nanA 0.031 0.0078b 0.052 0.0078b
a The median CI for each mutant is shown. It was calculated as follows: CI 
(MutantCFU/WTCFU)input/(MutantCFU/WTCFU)output.
b Statistically signiﬁcant difference (P  0.05).
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CFT073 nanA mutant was outcompeted by the wild type more
than 25-fold in both the spleen and the liver (Fig. 5), indicating
that metabolism of N-acetylneuraminic acid contributes signiﬁ-
cantly to systemic dissemination during UPEC bacteremia and
suggesting that sialic acids represent important bacterial carbon
sources in this niche.
DISCUSSION
Thisstudydescribesthedevelopmentandapplicationofamurine
modelofUPECbacteremia.Usingbiophotonicimaging,wedem-
onstrate that UPEC disseminates systemically after intravenous
inoculation of a sublethal dose, inﬁltrating tissues of multiple or-
gans. Colonization is a property of the UPEC strain and is not
observed in a laboratory strain. Testing of mutants defective for
known urovirulence factors further established that adherence,
heme acquisition, capsule, and sialic acid metabolism contribute
to UPEC ﬁtness during bacteremic dissemination and systemic
colonization independently of their roles in UTI. To our knowl-
edge, this is the ﬁrst study to examine the fate of a uropathogen
onceitentersthebloodstreamofanddisseminateswithinamam-
malian host.
Urosepsis, or sepsis caused by UTI, can occur during severe
cases of pyelonephritis when UPEC enters the circulation after
crossing the kidney proximal tubule epithelium and capillary en-
dothelialcells.AlthoughvertebrateanimalmodelsofsystemicEx-
PECinfectionhavebeenutilizedtoexamineE.colisepsis(15),the
fate of UPEC upon entry into the mammalian bloodstream at a
sublethaldosewasunknown.Themodeldescribedhereemploysa
relatively low inoculation dose and results in both tissue inﬁltra-
tion and colonization. Indeed, no morbidity or mortality was ob-
served in any infected mice, suggesting that neither LPS toxemia
norsepsiswasinduced.Consequently,useoftheID50,ratherthan
the LD50, to develop a bacteremia model allowed investigation of
UPEC infection immediately following bloodstream entry and
during subsequent dissemination but before the progression to
sepsis.
Overtime,systemicbacterialloadsgenerallydecreasedand7of
10 mice were free from detectable colonization by 1 week postin-
oculation, indicating that in this model, UPEC is cleared from
these tissues. In UTI models, infection duration and clearance are
inﬂuencedsigniﬁcantlybyhostfactorsthatdifferamongdifferent
inbred mouse strains (28), suggesting that mouse strain-speciﬁc
factorsmayalsocontributetobacteremiaoutcome.Inthismodel,
clearance is partially dependent on the dose administered, as in-
travenous inoculation with a 10-fold higher dose of CFT073
(107CFU)resultedin103CFU/gspleenorliverafter1week(2).
This is also in contrast to what has been observed for K1 ExPEC
strains, which replicate to high titers in the spleen, blood, and
brainfollowingintraperitonealinoculationof~101CFUinaneo-
natal rat model (29). Thus, although this study demonstrates that
UPECwithaK2capsuledisseminatesandinﬁltratestissueduring
bacteremia,itisclearlynotaswelladaptedtoabacteremiclifestyle
as ExPEC strains that produce K1 capsule.
ExPEC strains that produce K1 polysaccharide capsule are as-
sociated with neonatal meningitis (30) and have been shown to
cross the blood-brain barrier (31). In a neonatal rat model of
meningitis, a non-K1 strain was able to invade but not survive in
the brain (32). Surprisingly, CFT073, which produces a K2 cap-
sule, was occasionally recovered from the brains of intravenously
infected mice and was not eliminated from this site by cardiac
perfusion. As cerebrospinal ﬂuid was not quantitatively cultured,
it is unclear whether this represents a breach of the blood-brain
barrier. It is possible that, instead of penetration of the meninges,
the bacterial inﬁltration observed was due to trace amounts of
circulating blood remaining in brain-associated capillaries even
after perfusion was completed.
The results shown here suggest that a fraction of the intrave-
nously introduced CFT073 colonizes the gastrointestinal (GI)
tractandisexcretedbythemousethroughthissystem.Asearlyas
20 min postinoculation, the duodenum had signiﬁcant levels of
bacterial colonization and bacteria persisted in the cecum until at
FIG 5 UPEC virulence factor mutants in a cochallenge model of bacteremia.
Theindicatedisogenicmutantsweremixed1:1withwild-typeCFT073(except
forthekslcochallenge,whereCFT073Nalwasused),andCBA/Jmice(n8to
20) were inoculated intravenously with 106 CFU. CIs are shown for bacterial
recovery at 24 hpi in the (A) spleen and (B) liver. Bars indicate the medians,
and the dashed line represents a theoretical CI of 1. *, P  0.05.
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time points (24 and 48 hpi), which is consistent with clearing of
the bacteria through the GI tract. The ascending route of a UTI
from the fecal site into the urinary tract is considered the primary
route of transmission of UPEC. Thus, the ﬁnding that UPEC col-
onizestheGItractduringbacteremiaandissubsequentlyexcreted
in the feces has implications for UPEC transmission and the po-
tential for reinfection via the ascending route. Similarly, these
studies provide evidence against the model of a descending route
of UTI, as intravenous UPEC did not establish a persistent infec-
tion in the kidneys or bladder.
Introduced intravenously, pap and ﬁm L-OFF isogenic mu-
tants were outcompeted by the wild type in the spleen and liver,
indicating that ﬁmbria-mediated adherence contributes not only
to localized infection in the case of the urinary tract but also sys-
temic colonization. Interestingly, although type 1 ﬁmbriae are re-
quired by E. coli K1 to bind brain endothelial cells (33), a K1 ﬁm
locked-ONstrainthatconstitutivelyexpressestype1ﬁmbriaewas
unable to induce wild-type bacteremia in a neonatal rat model of
meningitis and neither ﬁm L-OFF nor ﬁm mutants were attenu-
ated for K1 bacteremia (34), suggesting a role for phase variation.
Further work is needed to determine whether our results, which
demonstratethecontributionoftype1ﬁmbriaetosystemictissue
colonization (but not necessarily bloodstream replication), are
consistent with these previous ﬁndings or whether they represent
adifferencebetweenE.coliK1andUPECbacteremias.Pﬁmbriae,
for which a deﬁnitive role in UTI has not been established (35),
bind to speciﬁc digalactoside moieties present on urothelial cells
(36) and erythrocytes (37). Together with our ﬁndings, this sug-
gests that the ability to adhere to erythrocytes or other host cells
may provide UPEC a competitive advantage during bacteremia.
In contrast, ﬂagella and hemolysin, known contributors to
UPEC colonization (5) and tissue damage (25) of the murine uri-
nary tract, did not play a signiﬁcant role in its systemic dissemi-
nationorcolonizationduringbacteremia.Thisisunlikewhatwas
observed for UPEC strain 536, which requires pathogenicity is-
lands I and II for lethality in an intravenous murine sepsis model,
a phenotype attributed to the loss of two hemolysin determinants
(11). Similarly, deletion of an E. coli K1 genomic island carrying
hemolysinandPﬁmbrialgenesabrogatedtheabilityofthisstrain
to cause neonatal rat bacteremia (38). A systemic role for hemo-
lysin may be strain speciﬁc, as Wiles et al. (21) also demonstrated
that hemolysin is dispensable for CFT073 systemic infection of
zebraﬁsh,althoughthistoxinwasrequiredbyotherUPECstrains.
TonB-dependent ferric iron acquisition systems, which are re-
quiredforUPECurinarytractcolonization(8),alsocontributeto
UPEC survival during bacteremia. Acquisition of heme, which
would be an abundant source of iron in the bloodstream, appears
to account for most of the requirement for tonB. Surprisingly, the
hmachuAmutantwassigniﬁcantlylessﬁtintheliverthanthetonB
mutant was. This implies that, in addition to their documented
TonB-dependent heme uptake functions (26, 39), Hma and/or
ChuA may have TonB-independent functions, such as adherence
(40). Alternatively, one or more TonB-dependent receptors may
have a negative impact on bacterial survival during UPEC bacte-
remic dissemination and colonization, perhaps by facilitating an-
timicrobial uptake, which was alleviated in the tonB mutant.
Capsule production is a common virulence factor among Ex-
PEC strains, and K2 capsule is required for CFT073 urinary tract
colonization and serum resistance (7). In both UPEC and avian
pathogenic E. coli, capsule synthesis genes were upregulated dur-
ing sepsis in chickens (41). K1 polysialic acid capsule is also re-
quiredbyExPECstrainsforvirulenceinaratmodelofmeningitis
(42), as well as for urothelial cell invasion by K1 UPEC strain
UTI89 in a murine UTI model (43). Our ﬁnding that capsule
contributes to the ﬁtness of UPEC once it gains access to the
bloodstream is consistent with these previous reports.
ThenanAmutant,whichlackstheabilitytodegradesialicacid,
had the largest competitive defect of any mutant tested in our
cochallenge model of UPEC bacteremia. Although not required
for ﬁtness in the murine urinary tract (9), an E. coli MG1655
nanAT mutant was defective for the establishment of intestinal
colonization in a streptomycin-treated mouse model (44). Thus,
it appears that host sialic acid may serve as a preferential carbon
source for E. coli in the GI tract and bloodstream but not in the
urinarytract.Sialicacidalsoinhibitstype1ﬁmbriationviarepres-
sion of the FimB recombinase (45), so it is possible that NanA-
mediated sialic acid catabolism is also important for maintaining
intracellular sialic acid homeostasis for optimal ﬁm expression
during UPEC bacteremia.
As for UTI, it appears that the presence of a single virulence
factor is not sufﬁcient for the development of UPEC bacteremia.
Even nanA, which, of the genes tested here, contributed the most
to infection, was necessary but not sufﬁcient to allow systemic
colonization. E. coli strain MG1655 encodes both nanA and ﬁm
but was unable to persist systemically. Although MG1655 also
encodes tonB, its genome contains fewer TonB-dependent iron
acquisition systems; for instance, it lacks a heme uptake system.
Consequently, it is probable that the presence of a number of
bacteremia ﬁtness determinants allows UPEC survival and sys-
temic dissemination. Other uropathogenicity and nonuroviru-
lencefactorslikelyalsocontributetoUPECsystemiccolonization,
and future delineation of these mechanisms in the bacteremia
modeldescribedherewillcontributetoouroverallunderstanding
of the progression to urosepsis.
MATERIALS AND METHODS
Bacterialstrains,plasmids,andcultureconditions.Thebacterialstrains
andplasmidsusedinthisstudyaresummarizedinTable2.Allstrainswere
cultured in Luria broth (10 g/liter tryptone, 5 g/liter yeast extract, 0.5 g/
liter NaCl) or on LB agar with the appropriate antibiotic (100 g/ml
ampicillin, 50 g/ml nalidixic acid, or 25 g/ml kanamycin) and incu-
bated at 37°C for 18 h.
Murine model of bacteremia. Female CBA/J mice (The Jackson Lab-
oratory, Bar Harbor, ME) aged 6 to 8 weeks were restrained using a Uni-
versal Restrainer (Braintree Scientiﬁc, Braintree, MA) and inoculated via
the tail vein over a 30-s period with a 100-l bacterial suspension deliv-
ering 102 to 106 CFU/mouse. The inoculum was prepared by resuspend-
ing overnight cultures in phosphate-buffered saline (PBS) and diluting
them to 1  103 to 1  107 CFU/ml. For cochallenges, wild-type and
mutant suspensions were mixed 1:1 before inoculation. When appropri-
ate, perfusion was performed on euthanized animals by cutting a small
holeintherightcardiacventricleandinfusingtheleftventricleslowlywith
40 ml 0.9% sterile saline before organ removal. Blanching of the organs
occurredwiththeﬁrst20mlofsterilesaline.Excisedtissueswerehomog-
enizedin3mlPBSusingamechanicalhomogenizer(OmniInternational,
Marietta, GA), and homogenate was plated onto LB agar using an Auto-
plate4000(SpiralBiotech,Norwood,MA)todeterminetheoutputnum-
ber of CFU/g tissue. For cochallenge experiments, homogenate was also
plated on appropriate antibiotic-containing agar to differentiate wild-
type and mutant strains. CIs were calculated by dividing the ratio of mu-
tanttowild-typebacteriaintheoutputbytheratioofmutanttowild-type
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sityCommitteeonUseandCareofAnimalsattheUniversityofMichigan
Medical School. Statistical signiﬁcance was determined using GraphPad
Prism 5 for independent challenges using the Mann-Whitney test and for
cochallenges using the Wilcoxon signed-rank test (with a hypothetical
value of 0) on log-transformed CI values.
In vivo bioluminescent imaging. Imaging was performed as de-
scribedpreviously(20).Thehairwascompletelyremovedfromthedorsal
and ventral sides of anesthetized mice using a Cordless Rechargeable An-
imal Trimmer Series 8900 (Wahl, United States) and cosmetic hair re-
moval treatment (Sensitive Skin VEET; Reckitt Benckiser, Parsippany,
NJ).MicewereinoculatedasdescribedabovewithE.coliCFT073(pGEN-
lux) and imaged at various time points using an IVIS 200 imaging system
(Xenogen)witha5-minexposuretime.Duringimaging,micewereanes-
thetized in chambers containing 2.0% isoﬂurane inhalant mixed with
oxygen (Baxter, Deerﬁeld, IL) via an IVIS manifold placed within the
imaging chamber. Photon emissions were obtained using the Living Im-
age software (Xenogen).
Mutant construction. Isogenic E. coli CFT073 tonB and E. coli
MG1644lacZmutants(Table2)wereconstructedusingtheRedrecom-
binase system (46). A kanamycin resistance cassette was PCR ampliﬁed
frompKD4(Table2)usingprimerscontainingsequencesinthe5=and3=
ends of tonB or lacZ. This product was used to replace 80% of the tonB
or lacZ gene by Red recombinase-mediated homologous recombination
(recombinase expressed from pKD46) in CFT073 or MG1655. Mutants
wereveriﬁedbyPCR,differentialEagIdigestion,andforthelacZmutant,
veriﬁcationofawhite-colonyphenotypeon80g/ml5-bromo-4-chloro-
3-indolyl--D-galactopyranoside (X-Gal) agar.
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